On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
In a statement Pfizer Inc said, it is recalling some batches of blood pressure drug Accuretic and two authorized cheaper versions of the drug citing the presence of elevated levels of a nitrosamine, a potential carcinogenic. Pfizer said it has not received… Read More ›
Belgian drugmaker Galapagos NV has named former Johnson & Johnson senior executive Paul Stoffels as its CEO, effective from April 1, 2022. Since 2012, Stoffels was the chief scientific officer at Johnson & Johnson and has spearheaded the development of its single-shot… Read More ›
In a statement drugmaker AstraZeneca said, a three-dose course of COVID-19 vaccine is effective against the Omicron variant of the coronavirus, citing data from an Oxford University lab study. The results of the study, which is yet to be published… Read More ›
In a significant development, Moderna’s CEO Stéphane Bancel said, it is unlikely that existing COVID-19 vaccines will be effective against the Omicron COVID-19 variant. With Bancel’s comments reaching the market, crude oil futures shed more than a dollar, the Nikkei gave… Read More ›
In a joint statement Danish drugmaker Novo Nordisk and U.S. drug developer Prothena Corp said, the former will acquire the latter’s experimental heart therapy PRX004, in a deal that could be worth up to $1.23 billion. Novo’s acquisition is in… Read More ›
According to an EU official involved in the negotiations to secure COVID-19 vaccines for the bloc, the European Union could potentially pay more than $10 billion to secure hundreds of millions of doses of vaccine candidates developed by Pfizer-BioNTech and… Read More ›
In a statement, the U.S. Department of Justice stated, Gilead Sciences Inc has agreed to settle allegations that it improperly used the Caring Voice Coalition as a conduit to cover thousands of patients’ co-payment obligations and has agreed to pay… Read More ›
Swiss drugmaker Roche has won approval from U.S. antitrust authorities for its $4.3 billion bid to acquire gene therapy specialist Spark Therapeutics. The development clears the way for Roche’s strategic push to position itself in the treatment of rare diseases,… Read More ›
According to a report from the Wall Street Journal, Swiss drugmaker Novartis AG is close to clinching an agreement to acquire U.S. biotechnology firm The Medicines Co for around $7 billion. In the potential deal, Novartis has agreed to pay… Read More ›
manageria.biz 